Table 3. Adverse Events by Randomized Study Group by Day 3 After Enrollmenta.
| Adverse events | No. (%) | |
|---|---|---|
| Azithromycin (n = 145) | Placebo (n = 72) | |
| Diarrhea | 60 (41) | 12 (17) |
| Nausea | 32 (22) | 7 (10) |
| Abdominal pain | 25 (17) | 1 (1) |
| Vomiting | 5 (3) | 2 (3) |
| Rash | 4 (3) | 2 (3) |
| Otherb | 10 (7) | 3 (4) |
| ≥1 Adverse events | 82 (57) | 19 (26) |
| ≥2 Adverse events | 38 (26) | 5 (7) |
a
Adverse events were recorded at day 3 of the trial to capture recent events following treatment administration and to ensure that participants had received their study medication package and taken the medication before completing the survey.
b
Other adverse events were recorded in an open text field and included abdominal pain, stomach cramps and diarrhea, fever, light-headedness, hives, fatigue, cough, anosmia, and painful respiration.